The Summer Intern will work closely with senior biostatisticians on statistical methodology and support for quantitative decision-making implementation in clinical trials.

Full time summer internship lasts about 10-12 weeks. Starting time is flexible around May or June 2026.

This can be a remote or hybrid internship onsite 3x a week in our Waltham, MA office. 

Basic Qualifications:

• Ph.D. candidate who has passed the qualifying exam in biostatistics, statistics, applied mathematics, or data sciences and is not expected to graduate prior to completion of the Summer 2026 internship.
• Have effective oral and written communication skills.
• Sufficient programming skills in SAS and/or R /or Python.

Preferred Qualifications:

• Proficient in R and had experience of R Shiny in developing, testing and deploying dashboards about statistical metrics
• Be able to conduct literature review independently.
• Experience in the development and application of advanced statistical methodologies or computational tools, with an emphasis on multiplicity adjustment techniques for Position 1 or Bayesian analytical approaches for Position 2.
• Experience with performing data analysis and simulations.
• Excellent in presenting project work to internal and external stakeholders.

The hourly rate for this position ranges from $30/hr to $32/hr. Exact compensation may vary based on skills, training, knowledge, and experience. Additional details can be found on our careers website: www.alkermes.com/careers#working-here  

Why join Team Alkermes?

Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.

We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts’ Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine. 

Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law.  Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA.  Alkermes is an E-Verify employer.